Second-generation antipsychotic medications and metabolic disturbance in children and adolescents
Abstract Background The second-generation antipsychotics (SGAs) are a group of antipsychotic drugs, used to treat psychiatric conditions. SGAs have been shown to precipitate rapid weight gain and dyslipidemia, as well as to promote insulin resistance, leading to the emergence of type 2 diabetes and...
Main Authors: | Samy Makary, Khaled Abd El Moez, Mona Elsayed, Haydy Hassan |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-01-01
|
Series: | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41983-023-00612-y |
Similar Items
-
The effects of antipsychotic medications on microbiome and weight gain in children and adolescents
by: Tali Bretler, et al.
Published: (2019-06-01) -
Second-generation antipsychotic and diabetes mellitus in children and adolescents
by: Carlo Ripoli, et al.
Published: (2017-12-01) -
The Effect of Long-Term Second-Generation Antipsychotics Use on the Metabolic Syndrome Parameters in Jordanian Population
by: Osama Abo Alrob, et al.
Published: (2019-06-01) -
Second generation antipsychotics causing neuroleptic malignant syndrome
by: C. Suraweera, et al.
Published: (2016-12-01) -
Some side effects and effcts on physical activity of second-generation antipsychotics: A study in children and adolescents
by: Soroor Arman, et al.
Published: (2014-01-01)